• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于水凝胶的血管化器官组织工程:腹部器官的系统综述

Hydrogel-Based Vascularized Organ Tissue Engineering: A Systematized Review on Abdominal Organs.

作者信息

Karageorgos Filippos F, Alexiou Maria, Tsoulfas Georgios, Alexopoulos Aleck H

机构信息

Department of Transplantation Surgery, Center for Research and Innovation in Solid Organ Transplantation, Aristotle University of Thessaloniki School of Medicine, 54642 Thessaloniki, Greece.

Chemical Process & Energy Resources Institute, 6th Km Harilaou-Thermi Rd., P.O. Box 60361, 57001 Thessaloniki, Greece.

出版信息

Gels. 2024 Oct 12;10(10):653. doi: 10.3390/gels10100653.

DOI:10.3390/gels10100653
PMID:39451306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11507150/
Abstract

BACKGROUND

Biomedical engineering, especially tissue engineering, is trying to provide an alternative solution to generate functional organs/tissues for use in various applications. These include beyond the final goal of transplantation, disease modeling and drug discovery as well. The aim of this study is to comprehensively review the existing literature on hydrogel-based vascularized organ (i.e., liver, pancreas, kidneys, intestine, stomach and spleen) tissue engineering of the abdominal organs.

METHODS

A comprehensive literature search was conducted on the Scopus database (latest search 1 September 2024). The research studies including hydrogel-based vascularized organ tissue engineering in the organs examined here were eligible for the review.

RESULTS

Herein, 18 studies were included. Specifically, 10 studies included the liver or hepatic tissue, 5 studies included the pancreas or pancreatic islet tissue, 3 studies included the kidney or renal tissue, 1 study included the intestine or intestinal or bowel tissue, 1 study included the stomach or gastric tissue, and 0 studies included spleen tissue.

CONCLUSION

Hydrogels are biocompatible materials with ideal characteristics for use as scaffolds. Even though organ tissue engineering is a rapidly growing field, there are still many obstacles to overcome to create a fully functional and long-lasting organ.

摘要

背景

生物医学工程,尤其是组织工程,正试图提供一种替代解决方案,以生成用于各种应用的功能性器官/组织。这些应用不仅包括移植的最终目标,还包括疾病建模和药物发现。本研究的目的是全面综述关于基于水凝胶的腹部器官(即肝脏、胰腺、肾脏、肠道、胃和脾脏)血管化器官组织工程的现有文献。

方法

在Scopus数据库上进行了全面的文献检索(最新检索时间为2024年9月1日)。在此处研究的器官中,包括基于水凝胶的血管化器官组织工程的研究符合纳入综述的条件。

结果

本文纳入了18项研究。具体而言,10项研究涉及肝脏或肝组织,5项研究涉及胰腺或胰岛组织,3项研究涉及肾脏或肾组织,1项研究涉及肠道或肠组织,1项研究涉及胃或胃组织,0项研究涉及脾脏组织。

结论

水凝胶是具有理想特性的生物相容性材料,可用作支架。尽管器官组织工程是一个快速发展的领域,但要创建一个功能完全且持久的器官,仍有许多障碍需要克服。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da44/11507150/17223bceec2a/gels-10-00653-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da44/11507150/17223bceec2a/gels-10-00653-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da44/11507150/17223bceec2a/gels-10-00653-g001.jpg

相似文献

1
Hydrogel-Based Vascularized Organ Tissue Engineering: A Systematized Review on Abdominal Organs.基于水凝胶的血管化器官组织工程:腹部器官的系统综述
Gels. 2024 Oct 12;10(10):653. doi: 10.3390/gels10100653.
2
Bioengineering vascularized tissue constructs using an injectable cell-laden enzymatically crosslinked collagen hydrogel derived from dermal extracellular matrix.利用源自真皮细胞外基质的可注射载细胞酶交联胶原蛋白水凝胶进行生物工程血管化组织构建。
Acta Biomater. 2015 Nov;27:151-166. doi: 10.1016/j.actbio.2015.09.002. Epub 2015 Sep 5.
3
Bioprinting for vascular and vascularized tissue biofabrication.用于血管和血管化组织生物制造的生物打印
Acta Biomater. 2017 Mar 15;51:1-20. doi: 10.1016/j.actbio.2017.01.035. Epub 2017 Jan 11.
4
Advances in Regenerative Medicine and Biomaterials.再生医学和生物材料的进展。
Methods Mol Biol. 2023;2575:127-152. doi: 10.1007/978-1-0716-2716-7_7.
5
Engineered Microfibers for Tissue Engineering.用于组织工程的工程微纤维
ACS Appl Bio Mater. 2024 Sep 16;7(9):5823-5840. doi: 10.1021/acsabm.4c00615. Epub 2024 Aug 15.
6
Engineering of Hydrogel Materials with Perfusable Microchannels for Building Vascularized Tissues.水凝胶材料的工程设计具有可灌注的微通道,用于构建血管化组织。
Small. 2020 Apr;16(15):e1902838. doi: 10.1002/smll.201902838. Epub 2019 Sep 26.
7
[Liver engineering as a new source of donor organs : A systematic review].[肝脏工程作为供体器官的新来源:一项系统综述]
Chirurg. 2016 Jun;87(6):504-13. doi: 10.1007/s00104-015-0015-y.
8
3D Bioprinting of Vascularized Tissues for and Applications.用于[具体应用场景未给出]和[具体应用场景未给出]应用的血管化组织的3D生物打印
Front Bioeng Biotechnol. 2021 May 13;9:664188. doi: 10.3389/fbioe.2021.664188. eCollection 2021.
9
Advancing bioinks for 3D bioprinting using reactive fillers: A review.使用反应性填料推进用于3D生物打印的生物墨水:综述。
Acta Biomater. 2020 Sep 1;113:1-22. doi: 10.1016/j.actbio.2020.06.040. Epub 2020 Jul 2.
10
Three-Dimensional Printing and Injectable Conductive Hydrogels for Tissue Engineering Application.三维打印与可注射导电水凝胶在组织工程中的应用。
Tissue Eng Part B Rev. 2019 Oct;25(5):398-411. doi: 10.1089/ten.TEB.2019.0100. Epub 2019 Sep 11.

引用本文的文献

1
Advances in Gelatin-Based Tissue Engineering Using HRP/HO.基于明胶的组织工程中使用辣根过氧化物酶/过氧化氢的研究进展。
Gels. 2025 Jun 16;11(6):460. doi: 10.3390/gels11060460.
2
Applications of Hydrogels in Emergency Therapy.水凝胶在急救治疗中的应用。
Gels. 2025 Mar 23;11(4):234. doi: 10.3390/gels11040234.
3
Evolving Transplant Oncology: Evolving Criteria for Better Decision-Making.不断发展的移植肿瘤学:用于更好决策的不断演变的标准。

本文引用的文献

1
Injectable Hydrogels in Cardiovascular Tissue Engineering.心血管组织工程中的可注射水凝胶
Polymers (Basel). 2024 Jul 1;16(13):1878. doi: 10.3390/polym16131878.
2
Liver bioprinting within a novel support medium with functionalized spheroids, hepatic vein structures, and enhanced post-transplantation vascularization.新型支撑介质内的肝脏生物打印,具有功能化球体、肝静脉结构和增强的移植后血管化。
Biomaterials. 2024 Dec;311:122681. doi: 10.1016/j.biomaterials.2024.122681. Epub 2024 Jun 25.
3
Emerging strategies for tissue engineering in vascularized composite allotransplantation: A review.
Diagnostics (Basel). 2025 Mar 24;15(7):820. doi: 10.3390/diagnostics15070820.
4
The Role of 3D Printing and Augmented Reality in the Management of Hepatic Malignancies.3D打印与增强现实在肝脏恶性肿瘤管理中的作用
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251323138. doi: 10.1177/15330338251323138.
5
Employing Polymer and Gel to Fabricate Scaffold-like Cancellous Orthopedic Screw: Polycaprolactone/Chitosan/Hydroxyapatite.采用聚合物和凝胶制备类支架松质骨矫形螺钉:聚己内酯/壳聚糖/羟基磷灰石。
Gels. 2025 Jan 2;11(1):28. doi: 10.3390/gels11010028.
血管化复合组织异体移植中组织工程的新兴策略:综述
J Tissue Eng. 2024 May 30;15:20417314241254508. doi: 10.1177/20417314241254508. eCollection 2024 Jan-Dec.
4
Vascular units as advanced living materials for bottom-up engineering of perfusable 3D microvascular networks.血管单元作为用于自下而上构建可灌注三维微血管网络的先进生物材料。
Bioact Mater. 2024 May 15;38:499-511. doi: 10.1016/j.bioactmat.2024.05.021. eCollection 2024 Aug.
5
Artificial kidney: Challenges and opportunities.人工肾脏:挑战与机遇。
World J Transplant. 2024 Mar 18;14(1):89025. doi: 10.5500/wjt.v14.i1.89025.
6
High-Scale 3D-Bioprinting Platform for the Automated Production of Vascularized Organs-on-a-Chip.用于自动化生产血管化器官芯片的高通量 3D 生物打印平台。
Adv Healthc Mater. 2024 Jul;13(17):e2304028. doi: 10.1002/adhm.202304028. Epub 2024 Apr 3.
7
A review of advanced hydrogels for cartilage tissue engineering.用于软骨组织工程的先进水凝胶综述。
Front Bioeng Biotechnol. 2024 Feb 8;12:1340893. doi: 10.3389/fbioe.2024.1340893. eCollection 2024.
8
3D hypoxia-mimicking and anti-synechia hydrogel enabling promoted neovascularization for renal injury repair and regeneration.3D 缺氧模拟和抗粘连水凝胶促进肾损伤修复和再生的新血管形成。
Mater Today Bio. 2023 Jun 7;21:100694. doi: 10.1016/j.mtbio.2023.100694. eCollection 2023 Aug.
9
Constructing biomimetic liver models through biomaterials and vasculature engineering.通过生物材料和血管工程构建仿生肝脏模型。
Regen Biomater. 2022 Oct 12;9:rbac079. doi: 10.1093/rb/rbac079. eCollection 2022.
10
Wearable and implantable artificial kidney devices for end-stage kidney disease treatment: Current status and review.用于终末期肾病治疗的可穿戴式和植入式人工肾装置:现状与综述。
Artif Organs. 2023 Apr;47(4):649-666. doi: 10.1111/aor.14396. Epub 2022 Sep 21.